Overland Pharmaceuticals
Wendy Yang has extensive experience in corporate development and strategy within the biotech sector, currently serving at Overland Pharmaceuticals since July 2020. Prior to this role, Wendy worked as a consultant at Putnam Associates, a top strategy consulting firm for healthcare clients. Wendy's earlier research experience includes positions at Yale University School of Medicine, contributing to a publication in *Science Translational Medicine*, and at Georgia Institute of Technology. Wendy Yang holds an MBA from Stanford University Graduate School of Business and a Bachelor of Science in Molecular, Cellular, and Developmental Biology from Yale University, graduating Cum Laude with a GPA of 3.87.
This person is not in any teams
This person is not in any offices
Overland Pharmaceuticals
Founded in 2020, Overland Pharmaceuticals is establishing a leading cross-border platform company focused on advanced modalities through strategic partnering and in-house R&D. Overland is seeded by Hillhouse Capital with access to global innovation and China biopharma ecosystem. Overland is building an initial oncology portfolio of first-in-class ADC and allogeneic cell therapy programs for greater China and Asia through partnering with established biotechs. Through formative R&D partnerships and in-house technology platforms, Overland will move forward the development and commercialization of the most promising advances in medicine.